MedPath

天津天士力（辽宁）制药有限责任公司

Ownership
-
Established
2003-03-03
Employees
-
Market Cap
-
Website
http://www.taslyln.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

136

NMPA:136

Drug Approvals

乌鸡白凤丸

Approval Number
国药准字Z21021638
Approval Date
Oct 18, 2023
NMPA

Valaciclovir Hydrochloride Tablets

Product Name
盐酸伐昔洛韦片
Approval Number
国药准字H20093082
Approval Date
Oct 18, 2023
NMPA

复方丹参片

Approval Number
国药准字Z21020381
Approval Date
Oct 18, 2023
NMPA

乌鸡白凤丸

Approval Number
国药准字Z21020356
Approval Date
Oct 18, 2023
NMPA

六味地黄丸

Approval Number
国药准字Z20063191
Approval Date
Oct 18, 2023
NMPA

红药片

Approval Number
国药准字Z21020347
Approval Date
Oct 18, 2023
NMPA

知柏地黄丸

Approval Number
国药准字Z21021639
Approval Date
Oct 9, 2023
NMPA

益心复脉颗粒

Approval Number
国药准字Z21021261
Approval Date
Oct 8, 2023
NMPA

大山楂丸

Approval Number
国药准字Z10800001
Approval Date
Oct 8, 2023
NMPA

坤灵丸

Approval Number
国药准字Z21021219
Approval Date
Oct 8, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 14
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.